Translator Disclaimer
25 May 2016 MicroRNAs and Their Impact on Radiotherapy for Cancer
Ann-Kathrin Mueller, Kirsten Lindner, Richard Hummel, Jörg Haier, David I. Watson, Damian J. Hussey
Author Affiliations +
Abstract

Resistance to radiation is considered to be an important reason for local failure after radiotherapy and tumor recurrence. However, the exact mechanisms of tumor resistance remain poorly understood. Current investigations of microRNAs as potential diagnostic and therapeutic tools for cancer treatment have shown promising results. With respect to radiotherapy resistance and response, there is now emerging evidence that microRNAs modulate key cellular pathways that mediate response to radiation. These data suggest that microRNAs might have significant potential as targets for the development of new therapeutic strategies to overcome radioresistance in cancer. This review summarizes the current literature pertinent to the influence of microRNAs in the response to radiotherapy for cancer treatment, with an emphasis on microRNAs as novel diagnostic and prognostic markers, as well as their potential to alter radiosensitivity.

© 2016 by Radiation Research Society.
Ann-Kathrin Mueller, Kirsten Lindner, Richard Hummel, Jörg Haier, David I. Watson, and Damian J. Hussey "MicroRNAs and Their Impact on Radiotherapy for Cancer," Radiation Research 185(6), 668-677, (25 May 2016). https://doi.org/10.1667/RR14370.1
Received: 4 January 2016; Accepted: 1 March 2016; Published: 25 May 2016
JOURNAL ARTICLE
10 PAGES


Share
SHARE
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top